Chen R, Ferris M, Wang S
Pharmacol Ther. 2020; 213:107583.
PMID: 32473160
PMC: 7434700.
DOI: 10.1016/j.pharmthera.2020.107583.
Chong S, Wilkinson A, Chawla S
Invert Neurosci. 2018; 18(4):15.
PMID: 30406849
DOI: 10.1007/s10158-018-0220-8.
Jenkins P, Mehta M, Sharp D
Brain. 2016; 139(Pt 9):2345-71.
PMID: 27256296
PMC: 4995357.
DOI: 10.1093/brain/aww128.
Simpson N, Maffei A, Freeby M, Burroughs S, Freyberg Z, Javitch J
Mol Endocrinol. 2012; 26(10):1757-72.
PMID: 22915827
PMC: 3458225.
DOI: 10.1210/me.2012-1101.
Chen H, Ruan N, Chen J, Lin T
ASN Neuro. 2012; 4(6):371-82.
PMID: 22909302
PMC: 3449306.
DOI: 10.1042/AN20120013.
Drosophila Dopamine2-like receptors function as autoreceptors.
Vickrey T, Venton B
ACS Chem Neurosci. 2012; 2(12):723-729.
PMID: 22308204
PMC: 3269839.
DOI: 10.1021/cn200057k.
Antisense-mediated RNA targeting: versatile and expedient genetic manipulation in the brain.
Zalachoras I, Evers M, van Roon-Mom W, Aartsma-Rus A, Meijer O
Front Mol Neurosci. 2011; 4:10.
PMID: 21811437
PMC: 3142880.
DOI: 10.3389/fnmol.2011.00010.
Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate.
Michaelides M, Pascau J, Gispert J, Delis F, Grandy D, Wang G
Eur J Neurosci. 2010; 32(4):668-76.
PMID: 20646063
PMC: 2938021.
DOI: 10.1111/j.1460-9568.2010.07319.x.
Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis.
Bales J, Wagner A, Kline A, Dixon C
Neurosci Biobehav Rev. 2009; 33(7):981-1003.
PMID: 19580914
PMC: 2806224.
DOI: 10.1016/j.neubiorev.2009.03.011.
Getting specialized: presynaptic and postsynaptic dopamine D2 receptors.
De Mei C, Ramos M, Iitaka C, Borrelli E
Curr Opin Pharmacol. 2009; 9(1):53-8.
PMID: 19138563
PMC: 2710814.
DOI: 10.1016/j.coph.2008.12.002.
Enhanced latent inhibition in dopamine receptor-deficient mice is sex-specific for the D1 but not D2 receptor subtype: implications for antipsychotic drug action.
Bay-Richter C, OTuathaigh C, OSullivan G, Heery D, Waddington J, Moran P
Int J Neuropsychopharmacol. 2008; 12(3):403-14.
PMID: 19012810
PMC: 2760776.
DOI: 10.1017/S1461145708009656.
Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders.
Roy K, Murtie J, El-Khodor B, Edgar N, Sardi S, Hooks B
Proc Natl Acad Sci U S A. 2007; 104(19):8131-6.
PMID: 17483467
PMC: 1876583.
DOI: 10.1073/pnas.0702157104.
Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice.
Li Z, Schmauss C, Cuenca A, Ratcliffe E, Gershon M
J Neurosci. 2006; 26(10):2798-807.
PMID: 16525059
PMC: 6675162.
DOI: 10.1523/JNEUROSCI.4720-05.2006.
Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.
Waddington J, OTuathaigh C, OSullivan G, Tomiyama K, Koshikawa N, Croke D
Psychopharmacology (Berl). 2005; 181(4):611-38.
PMID: 16041535
DOI: 10.1007/s00213-005-0058-8.
Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice.
Kobayashi M, Iaccarino C, Saiardi A, Heidt V, Bozzi Y, Picetti R
Proc Natl Acad Sci U S A. 2004; 101(31):11465-70.
PMID: 15272078
PMC: 509223.
DOI: 10.1073/pnas.0402028101.
